After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Biogen Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Biogen Inc is $23.44B. A total of 1.21 million shares were traded on the day, compared to an average of 1.39M shares.
In the most recent transaction, Singhal Priya sold 431 shares of BIIB for 204.22 per share on Sep 03 ’24. After the transaction, the Head of Development now owns 5,316 company shares. In a previous transaction on Sep 03 ’24, Singhal Priya bought 431 shares at 204.22 per share.
Among the insiders who sold shares, Singhal Priya disposed of 93 shares on Apr 02 ’24 at a per-share price of $213.09. This resulted in the Head of Development holding 4,886 shares of BIIB after the transaction. In another insider transaction, Singhal Priya sold 262 shares at $221.23 per share on Feb 22 ’24. Company shares held by the Head of Development now total 4,886.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BIIB has a high of $268.30 and a low of $153.62.
As of this writing, BIIB has an earnings estimate of $3.44 per share for the current quarter. EPS was calculated based on a consensus of 28.0 estimates, with a high estimate of $3.85 per share and a lower estimate of $3.13. The company reported an EPS of $2.95 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BIIB’s latest balance sheet shows that the firm has $3.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.60B in debt and $4.30B in liabilities at the time. Its Book Value Per Share was $112.28, while its Total Shareholder’s Equity was $10.96B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BIIB is Buy with a score of 4.16.
